Maria A. López-Olivo, M.D., M.Sc., Ph.D.

Peer-Reviewed Articles

1. López -Olivo MA, Zogala RJ, des Bordes J, Zamora NV, Christensen R, Rai D, Goel N, Carmona L, Pratt G, Strand V, Suarez-Almazor ME. Outcomes Reported in Prospective Long-Term Observational Studies and Registries of Patients with Rheumatoid Arthritis Worldwide: An OMERACT Systematic Review. Arthritis Care Res (Hoboken) 73(5):649-657, 2021. e-Pub 2020. PMID: 32004421.
2. des Bordes JKA, Foreman J, Westrich-Robertson T, López -Olivo MA, Peterson SK, Hofstetter C, Lyddiatt A, Willcockson I, Leong A, Suarez-Almazor ME. Interactions and perceptions of patients with rheumatoid arthritis participating in an online support group. Clin Rheumatol 39(6):1775-1782, 2020. e-Pub 2020. PMID: 32006180.
3. Karpes Matusevich AR, Suarez-Almazor ME, Cantor SB, Lal LS, Swint JM,López -Olivo MA. Systematic review of economic evaluations of cycling versus swapping in patients with rheumatoid arthritis after failure to tumor necrosis factor inhibitors. Arthritis Care Res (Hoboken) 72(3):343-352, 2020. PMID: 30801951.
4. López -Olivo MA, Colmegna I, Karpes Matusevich AR, Qi SR, Zamora NV, Sharma R, Pratt G, Suarez-Almazor ME. Systematic Review of Recommendations on the Use of Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis and Cancer. Arthritis Care Res (Hoboken) 72(3):309-318, 2020. PMID: 30821928.
5. des Bordes J, Prasad S, Pratt G, Suarez-Almazor ME, López-Olivo MA. Knowledge, beliefs, and concerns about bone health from a systematic review and metasynthesis of qualitative studies. PLoS One 15(1):e0227765, 2020. e-Pub 2020. PMID: 31940409.
6. Durán-Crane A, Laserna A, López -Olivo MA, Cuenca JA, Díaz DP, Cardenas YR, Urso C, O'Connell K, Azimpoor K, Fowler C, Price KJ, Sprung CL, Nates JL. Clinical Practice Guidelines and Consensus Statements About Pain Management in Critically Ill End-of-Life Patients: A Systematic Review. Crit Care Med 47(11):1619-1626, 2019. PMID: 31517694.
7. Smith GL, López -Olivo MA, Advani PG, Ning MS, Geng Y, Giordano SH, Volk RJ. Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes. J Natl Compr Canc Netw 17(10):1184-1192, 2019. PMID: 31590147.
8. López -Olivo MA, Negrón JB, Zogala RJ, Carmona L, Criner K, Goel N, Gonzalez-Lopez L, Ingegnoli F, Leong A, March L, Shea B, Strand V, Tugwell P, Westrich-Robertson T, Zamora NV, Christensen R, Suarez-Almazor ME. Core Outcome Sets Specifically for Longterm Observational Studies: OMERACT Special Interest Group Update in Rheumatoid Arthritis. J Rheumatol 46(9):1164-1167, 2019. PMID: 30824644.
9. Yap A, López -Olivo MA, Dubowitz J, Hiller J, Riedel B, Global Onco-Anesthesia Research Collaboration Group. Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Can J Anaesth 66(5):546-561, 2019. PMID: 30834506.
10. Abdel-Wahab N, Rai D, Siddhanamatha H, Dodeja A, Suarez-Almazor ME, López -Olivo MA. A comprehensive scoping review to identify standards for the development of health information resources on the internet. PLoS One 14(6):e0218342, 2019. PMID: 31220126.
11. López -Olivo MA, Kakpovbia-Eshareturi V, des Bordes JK, Barbo A, Christensen R, Suarez-Almazor ME. Treating Early Undifferentiated Arthritis: A Systematic Review and Meta-Analysis of Direct and Indirect Trial Evidence. Arthritis Care Res (Hoboken) 70(9):1355-1365, 2018. PMID: 29161466.
12. des Bordes JKA, Gonzalez E, López -Olivo MA, Shethia M, Nayak P, Suarez-Almazor ME. Assessing information needs and use of online resources for disease self-management in patients with rheumatoid arthritis: a qualitative study. Clin Rheumatol 37(7):1791-1797, 2018. PMID: 29500557.
13. Yap A, López -Olivo MA, Dubowitz J, Pratt G, Hiller J, Gottumukkala V, Sloan E, Riedel B, Schier R. Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies. Br J Anaesth 121(1):45-57, 2018. PMID: 29935594.
14. Abdel-Wahab N, Talathi S, López -Olivo MA, Suarez-Almazor ME. Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis. Lupus 27(4):572-583, 2018. PMID: 28945149.
15. López -Olivo MA, Ingleshwar A, Volk RJ, Jibaja-Weiss M, Barbo A, Saag K, Leong A, Suarez-Almazor ME. Development and Pilot Testing of Multimedia Patient Education Tools for Patients with Knee Osteoarthritis, Osteoporosis, and Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 70(2):213-220, 2018. PMID: 28464546.
16. Abdel-Wahab N, Shah M, López -Olivo MA, Suarez-Almazor ME. Use of Immune Checkpoint Inhibitors in the Treatment of Patients With Cancer and Preexisting Autoimmune Disease: A Systematic Review. Ann Intern Med 168(2):121-130, 2018. PMID: 29297009.
17. Zamora NV, Christensen R, Goel N, Klokker L, López -Olivo MA, Kristensen LE, Carmona L, Strand V, Curtis JR, Suarez-Almazor ME. Critical Outcomes in Longitudinal Observational Studies and Registries in Patients with Rheumatoid Arthritis: An OMERACT Special Interest Group Report. J Rheumatol 44(12):1894-1898, 2017. PMID: 28620065.
18. He T, López -Olivo MA, Hur C, Chhatwal J. Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6. Aliment Pharmacol Ther 46(8):711-721, 2017. PMID: 28836278.
19. des Bordes JKA, Suarez-Almazor ME, Volk RJ, Lu H, Edwards B, López -Olivo MA. Online Educational Tool to Promote Bone Health in Cancer Survivors. J Health Commun 22(10):808-817, 2017. PMID: 28922062.
20. Chhatwal J, He T, Hur C, López -Olivo MA. Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-Saving. Clin Gastroenterol Hepatol 15(6):827-837.e8, 2017. PMID: 27650326.
21. Siddhanamatha HR, Heung E, López -Olivo MA, Abdel-Wahab N, Ojeda-Prias A, Willcockson I, Leong A, Suarez-Almazor ME. Quality assessment of websites providing educational content for patients with rheumatoid arthritis. Semin Arthritis Rheum 46(6):715-723, 2017. PMID: 28258768.
22. Pundole X, Cheema HI, Petitto GS, López -Olivo MA, Suarez-Almazor ME, Lu H. Prevention and treatment of bone loss and fractures in patients undergoing a hematopoietic stem cell transplant: a systematic review and meta-analysis. Bone Marrow Transplant 52(5):663-670, 2017. PMID: 28112742.
23. Pan X, López -Olivo MA, Song J, Pratt G, Suarez-Almazor ME. Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis. BMJ Open 7(3):e013242, 2017. PMID: 28249848.
24. Singh JA, Hossain A, Tanjong Ghogomu E, Mudano AS, Maxwell LJ, Buchbinder R, López -Olivo MA, Suarez-Almazor ME, Tugwell P, Wells GA. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Cochrane Database Syst Rev 3:CD012591, 2017. PMID: 28282491.
25. Abdel-Wahab N, López -Olivo MA,, Pinto-Patarroyo GP, Suarez-Almazor ME. Systematic review of case reports of antiphospholipid syndrome following infection. Lupus 25(14):1520-1531, 2016. PMID: 27060064.
26. Bruera S, Barbo AG, López -Olivo MA,. Use of medication reminders in patients with rheumatoid arthritis. Rheumatol Int 36(11):1543-1548, 2016. PMID: 27590013.
27. Volk RJ, Linder SK, López -Olivo MA,, Kamath GR, Reuland DS, Saraykar SS, Leal VB, Pignone MP. Patient Decision Aids for Colorectal Cancer Screening: A Systematic Review and Meta-analysis. Am J Prev Med 51(5):779-791, 2016. PMID: 27593418.
28. Waimann CA, Fernandez-Mazarambroz RJ, Cantor SB, López-Olivo MA, Barbo AG, Landon GC, Siff SJ, Lin H, Suarez-Almazor ME. Effect of Body Mass Index and Psychosocial Traits on Total Knee Replacement Costs in Patients with Osteoarthritis. J Rheumatol 43(8):1600-6, 2016. PMID: 27307528.
29. des Bordes JK, Abdel-Wahab N, Suarez-Almazor M, Lopez-Olivo MA. Assessing information needs on bone health in cancer survivors. J Cancer Surviv 10(3):480-8, 2016. e-Pub 2015. PMID: 26499252.
30. Prescott LS, Taylor JS, López-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC. How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. Cancer Treat Rev 46:1-8, 2016. PMID: 27046422.
31. López-Olivo MA, Amezaga Urruela M, McGahan L, Pollono EN, Suarez-Almazor ME. Rituximab for rheumatoid arthritis. Cochrane Database Syst Rev 1:CD007356, 2015. PMID: 25603545.
32. López-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME. Methotrexate for treating rheumatoid arthritis. Cochrane Database Syst Rev(6):CD000957, 2014. PMID: 24916606.
33. Waimann CA, Fernandez-Mazarambroz RJ, Cantor SB, López-Olivo MA, Zhang H, Landon GC, Siff SJ, Suarez-Almazor ME. Cost-effectiveness of total knee replacement: a prospective cohort study. Arthritis Care Res (Hoboken) 66(4):592-9, 2014. PMID: 24124052.
34. de Achaval S, Kallen MA, Mayes MD, López-Olivo MA, Suarez-Almazor ME. Use of the Patient-generated Index in systemic sclerosis to assess patient-centered outcomes. J Rheumatol 40(8):1337-43, 2013. PMID: 23772081.
35. Lethaby A, López-Olivo MA, Maxwell L, Burls A, Tugwell P, Wells GA. Etanercept for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev(5):CD004525, 2013. PMID: 23728649.
36. Peddi P, López-Olivo MA, Pratt GF, Suarez-Almazor ME. Denosumab in patients with cancer and skeletal metastases. Cancer Treat Rev 39(1):97-104, 2013. e-Pub 2012. PMID: 22898302.
37. López-Olivo MA, Pratt G, Palla S, Salahudeen A. Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis. Am J Kidney Dis 62(3):481-92, 2013. PMID: 23684124.
38. López-Olivo MA, Shah NA, Pratt G, Risser JM, Symanski E, Suarez-Almazor ME. Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis. Support Care Cancer 20(11):2985-98, 2012. PMID: 22956190.
39. Tayar JH, López-Olivo MA, Suarez-Almazor ME. Febuxostat for treating chronic gout. Cochrane Database Syst Rev 11:CD008653, 2012. PMID: 23152264.
40. López-Olivo MA, Tayar JH, Martinez-López JA, Pollono EN, Cueto JP, Gonzales-Crespo MR, Fulton S, Suarez-Almazor ME. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. JAMA 308(9):898-908, 2012. PMID: 22948700.
41. López-Olivo MA, Andrabi TR, Palla SL, Suarez-Almazor ME. Cervical spine radiographs in patients with rheumatoid arthritis undergoing anesthesia. J Clin Rheumatol 18(2):61-6, 2012. PMID: 22334269.
42. López-Olivo MA, Landon GC, Siff SJ, Edelstein D, Pak C, Kallen MA, Stanley M, Zhang H, Robinson KC, Suarez-Almazor ME. Psychosocial determinants of outcomes in knee replacement. Ann Rheum Dis 70(10):1775-81, 2011. PMID: 21791452.
43. Singh JA, Beg S, López-Olivo MA,. Tocilizumab for rheumatoid arthritis: a Cochrane systematic review. J Rheumatol 38(1):10-20, 2011. PMID: 20952462.
44. Pollono EN, López-Olivo MA, López JA, Suarez-Almazor ME. A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis. Clin Rheumatol 29(9):947-55, 2010. PMID: 20383550.
45. Singh JA, Beg S, López-Olivo MA,. Tocilizumab for rheumatoid arthritis. Cochrane Database Syst Rev 7(7):CD008331, 2010. PMID: 20614469.
46. Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, López-Olivo MA, Ghogomu ET, Tugwell P. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Sao Paulo Med J 128(5):309-10, 2010. PMID: 21181074.
47. Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, López-Olivo MA, Ghogomu ET, Tugwell P. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. CMAJ 181(11):787-96, 2009. PMID: 19821440.
48. Maillefert JF, Kloppenburg M, Fernandes L, Punzi L, Günther KP, Martin Mola E, Lohmander LS, Pavelka K, López-Olivo MA,, Dougados M, Hawker GA. Multi-language translation and cross-cultural adaptation of the OARSI/OMERACT measure of intermittent and constant osteoarthritis pain (ICOAP). Osteoarthritis Cartilage 17(10):1293-6, 2009. PMID: 19410033.
49. Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, López-Olivo MA,Tanjong Ghogomu E, Tugwell P. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev(4):CD007848, 2009. PMID: 19821440.
50. Aguilar-Chavez EA, Gamez-Nava JI, López-Olivo MA, Galvan-Melendres S, Corona-Sanchez EG, Loaiza-Cardenas CA, Celis A, Cardona-Muñoz EG, Gonzalez-Lopez L. Circulating leptin and bone mineral density in rheumatoid arthritis. J Rheumatol 36(3):512-6, 2009. PMID: 19208597.
51. Roundtree AK, Kallen MA, López-Olivo MA, Kimmel B, Skidmore B, Ortiz Z, Cox V, Suarez-Almazor ME. Poor reporting of search strategy and conflict of interest in over 250 narrative and systematic reviews of two biologic agents in arthritis: a systematic review. J Clin Epidemiol 62(2):128-37, 2009. PMID: 19013763.
52. Corona-Sanchez EG, Gonzalez-López L, Muñoz-Valle JF, Vazquez-Del Mercado M, López-Olivo MA, Aguilar-Chavez EA, Salazar-Paramo M, Loaiza-Cardenas C, Oregon-Romero E, Navarro-Hernandez RE, Gamez-Nava JI. Circulating e-selectin and tumor necrosis factor-alpha in extraarticular involvement and joint disease activity in rheumatoid arthritis. Rheumatol Int 29(3):281-6, 2009. PMID: 18726101.
53. López-Olivo MA, Kallen MA, Ortiz Z, Skidmore B, Suarez-Almazor ME. Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: a systematic review. Arthritis Rheum 59(11):1625-38, 2008. PMID: 18975351.
54. Gonzalez-López L, Sanchez-Hernandez JD, Aguilar-Chavez EA, Cota-Sanchez AR, López-Olivo MA, Villa-Manzano AI, Ortega-Flores R, Espinoza-Magaña GL, Rojo-Contreras W, Cardona-Muñoz EG, Gamez-Nava JI. Hyperhomocysteinemia in ankylosing spondylitis: prevalence and association with clinical variables. Rheumatol Int 28(12):1223-8, 2008. PMID: 18719918.
55. Gossec L, Jordan JM, Mazzuca SA, Lam MA, Suarez-Almazor ME, Renner JB, López-Olivo MA, Hawker G, Dougados M, Maillefert JF, OARSI-OMERACT task force "total articular replacement as outcome measure in OA". Comparative evaluation of three semi-quantitative radiographic grading techniques for knee osteoarthritis in terms of validity and reproducibility in 1759 X-rays: report of the OARSI-OMERACT task force. Osteoarthritis Cartilage 16(7):742-8, 2008. PMID: 18417373.
56. Villa-Manzano AI, Gamez-Nava JI, Salazar-Paramo M, Valera-Gonzalez IC, Garcia-Gonzalez A, Garcia-Gonzalez G, Morales-Romero J, López-Olivo MA, Galvan-Ramirez LM, Ruiz-Ruvalcaba R, Cardona-Muñoz EG, Gonzalez-Lopez L. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus. Rheumatol Int 26(8):712-6, 2006. PMID: 16231121.
57. López-Olivo MA, Gonzalez-López L, Garcia-Gonzalez A, Villa-Manzano AI, Cota-Sanchez AR, Salazar-Paramo M, Varon-Villalpando E, Cardona-Muñoz EG, Gamez-Nava JI. Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis. Scand J Rheumatol 35(2):112-6, 2006. PMID: 16641044.
58. Morales-Romero J, Cázares-Méndez JM, Gámez-Nava JI, Triano-Páez M, Villa-Manzano AI, López-Olivo MA, Rodríguez-Arreola BE, González-López L. [Patterns of health care in an out patient rheumatologic clinic]. Reumatol Clin 1(2):87-94, 2005. PMID: 21794243.

Invited Articles

1. López-Olivo MA, Suarez-Almazor ME. Digital Patient Education and Decision Aids. Rheum Dis Clin North Am 45(2):245-256, 2019. PMID: 30952396.
2. Chhatwal J, He T, López-Olivo MA. Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals. Pharmacoeconomics 34(6):551-67, 2016. PMID: 26748919.
3. López-Olivo MA, Lu H, Tayar JH. Review of tofacitinib in rheumatoid arthritis. Clinical Investigation 5(1):23-38, 2015.
4. Tayar JH, López-Olivo MA, Suarez-Almazor ME. Adalimumab: eight years of experience in rheumatoid arthritis. International Journal of Clinical Rheumatology 8(2):165-84, 2013.
5. López-Olivo MA, Tayar JH. Safety concerns on the use of biologic drugs for the treatment of rheumatoid arthritis. CML Rhematology 31(4):101-16, 2012.
6. López-Olivo MA, Suarez-Almazor ME. Developing guidelines in musculoskeletal disorders. Clin Exp Rheumatol 25(6 Suppl 47):28-36, 2007. PMID: 18021504.

Manuals, Teaching Aids, Other Teaching Publications

1. . Osteoporosis: treatments that help prevent broken bones a guide for women after menopause.|| DVD English and Spanish. The Agency for Healthcare Research and Quality (AHRQ), 2013.
2. . Osteoarthritis of the knee: a guide for adults.|| DVD English and Spanish. The Agency for Healthcare Research and Quality (AHRQ), 2013.
3. . Rheumatoid arthritis: choosing the right medicine.|| DVD English and Spanish. The Agency for Healthcare Research and Quality (AHRQ), 2013.
4. . Healthy Bones: A decision aid for women with osteoporosis. The Agency for Healthcare Research and Quality (AHRQ): www.effectivehealthcare.ahrq.gov/ehc/decisionaids/osteoporosis/LM5/pdfs/AboutTheDecisionAid.pdf, 2012.

Other Articles

1. Suarez-Almazor ME, Ortiz Z, López-Olivo MA, Moffett ML, Pak C, Skidmore B, Kimmel B, Kallen MA, Cox VL Long-term clinical and cost-effectiveness of infliximab and etanercept for rheumatoid arthritis. Canadian Agency for Drugs and Technologies in Health, 2007.
2. Suarez-Almazor ME, Ortiz Z, López-Olivo MA, Moffett ML, Pak C, Skidmore B, Kimmel B, Kallen MA, Cox VL Infliximab and etanercept in rheumatoid arthritis: systematic review of long-term clinical effectiveness, safety, and cost-effectiveness. Canadian Agency for Drugs and Technologies in Health, 2007.
3. Suarez-Almazor ME, Ortiz Z, López-Olivo MA, Pak C, Skidmore B, Kimmel B, Kallen MA, Cox VL, Roundtree A Infliximab and etanercept in rheumatoid arthritis: timing, dose escalation, and switching. Canadian Agency for Drugs and Technologies in Health, 2007.

Editorials

1. López-Olivo MA, Tayar J, Suarez-Almazor ME. The updated guidelines on the use of rituximab in rheumatoid arthritis: Existing challenges and future opportunities. Rheumatology 50(12):2153-4, 2011. PMID: 21546350.

Abstracts

1. Karpes-Matusevich A, Lal LS, Chan W, Swint JM, Cantor SB, Suarez-Almazor ME, López -Olivo MA. Discontinuation plays a role when evaluating the cost effectiveness of the second biological drug for patients with rheumatoid arthritis. ISPOR, 2020.
2. Karpes-Matusevich A, Lal LS, Chan W, Swint JM, Cantor SB, Suarez-Almazor ME, López -Olivo MA. Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy failure in patients with rheumatoid arthritis. ISPOR, 2020.
3. López -Olivo MA, Volk R, Krause K, Suarez-Almazor ME. A review of smoking cessation strategies and lung cancer screening practices in patients with rheumatoid arthritis. EULAR, 2020.
4. López -Olivo MA, Colmegna I, Karpes AR, Qi SR, Zamora NV, Pratt G, Suarez-Almazor ME. Systematic review of recommendations on the pharmacological management of cancer survivors with concomitant rheumatoid arthritis. 7th State of the Science Cancer Survivorship Research Symposium, 2019.
5. Volk RJ, Lowenstein LM, Nishi SPE, Mendoza TR, Crocker LC, López -Olivo MA, Choi N, Sepucha K. The Quality of Lung Cancer Screening Decisions by Patients at Two Academic Cancer Centers. Abstract presented at the 10th International Shared Decision Making Conference, ISDM 2019, Quebec, Canada, 2019.
6. Yap A, López -Olivo MA, Dubowitz J, Hiller J, Riedel B. Anaesthetic Technique and Cancer Outcomes: A Meta-Analysis of Total Intravenous vs. Volatile Anaesthesia. ANZCA ASM 2019 66(5):546-561, 2019.
7. López -Olivo MA, des Bordes JKA, Pratt G, Suarez-Almazor M. Prescriber attitudes and beliefs about triple therapy for patients with rheumatoid arthritis: knowledge exchange in internet forums and social media. JCR 2019 Annual Scientific Meeting, 2019.
8. Abdel-Wahab N, Houssein S, López -Olivo MA, Diab A, Suarez-Almazor ME. Checkpoint inhibitors in patients with cancer and rheumatologic diseases: a systematic review of the literature. Ann Rheum Dis volume 78, supplement Suppl, year 2019, 2019.
9. Yap A, López -Olivo MA, Dubowitz J, Hiller J, Riedel B. Collaboration G Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia Australian and New Zealand College of Anaesthetists (ANZCA). Annual Scientific Meeting conference, 2019.
10. López -Olivo MA, Abdel-Wahab N, Suárez-Almazor M. A Systematic Review and Meta-analysis of Observational Studies Reporting on the Use of Checkpoint Inhibitors in Patients with Cancer and Pre-existing Autoimmune Disease. Arthritis Rheumatol 71 (Suppl 10), 2019.
11. Karpes A, Duan Z, Zhao H, Lal L, Chan W, Suárez-Almazor M, Giordano S, Swint J, López -Olivo MA. Treatment Sequences, Effectiveness, and Costs of Tumor Necrosis Factor Inhibitor Cycling Compared with Swapping to a Novel Disease-modifying Anti-rheumatic Drug in Rheumatoid Arthritis Patients. Arthritis Rheumatol 71 (Suppl 10), 2019.
12. des Bordes J, Foreman J, López -Olivo MA, Peterson S, Westrich-Robertson T, Hofstetter C, Lyddiatt A, Leong A, Suárez-Almazor M. Physical Challenges in RA: A Qualitative Study of an Online Patient Support Group. Arthritis Rheumatol 71 (Suppl 10), 2019.
13. Zogala R, Criner K, López -Olivo MA, Zamora N, Rai D, Pratt G, des Bordes JKA, Christensen R, Suarez-Almazor M. Patient-reported outcome measures used in rheumatoid arthritis cohorts and registries around the world: an environmental scan from the outcome measures in rheumatology critical outcomes in longitudinal observational studies working group. Arthritis Rheumatol 70 (Suppl 10), 2018.
14. López -Olivo MA, des Bordes JKA, Pratt G, Suarez-Almazor M. Prescriber attitudes and beliefs about triple therapy for patients with rheumatoid arthritis: knowledge exchange in internet forums and social media. Arthritis Rheumatol 70 (Suppl 10), 2018.
15. López -Olivo MA, Tayar J, Zamora N, Pratt G, Suarez-Almazor M. Malignancies and serious infections in randomized controlled trials of janus kinase inhibitors in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Rheumatol 70 (Suppl 9):66, 2018.
16. López -Olivo MA, Matusevich A, Cantor SB, Pratt G, Suarez-Almazor M. The comparative effectiveness of cycling tumor necrosis factor inhibitor (TNFi) versus swapping to a nonTNFi on patient-reported functional ability of patients with rheumatoid arthritis. Arthritis Rheumatol 70 (Suppl 9), 2018.
17. López -Olivo MA, Foreman J, Lin H, Leung CH, Westrich-Robertson T, Hofstetter C, Peterson SK, Lyddiatt A, Leong AL, Willcockson IU, Suarez-Almazor M. Effects of Social Networking on Chronic Disease Management in Rheumatoid Arthritis. PRISM health symposium, 2018.
18. López -Olivo MA, Matusevich A, Suarez-Almazor ME. Cycling versus swapping in patients with rheumatoid arthritis with an inadequate response to at least one tumor necrosis factor alpha inhibitor: a systematic review and meta-analysis of observational studies. Ann Rheum Dis 76(Suppl 2), 2017.
19. des Bordes J, Prasad S, Pratt G, Suarez-Almazor M, López -Olivo MA. Knowledge, beliefs and concerns about osteoporosis - a qualitative synthesis. Arthritis Rheumatol 69 (Suppl 10), 2017.
20. López -Olivo MA, Colmegna I, Matusevich A, Q SR, Zamora N, Sharma R, Pratt G, Suarez-Almazor ME. Recommendations on the management of rheumatoid arthritis in patients with cancer: a systematic review of clinical practice guidelines and consensus statements. Arthritis Rheumatol 69 (Suppl 10), 2017.
21. Matusevich A, Suarez-Almazor M, Cantor SB, López -Olivo MA. Systematic review of modelling approaches and quality for the cost effectiveness of sequential targeted therapy in patients with rheumatoid arthritis that show an inadequate response to at least one tumor necrosis factor alpha inhibitor. Arthritis Rheumatol 69 (Suppl 10), 2017.
22. Abdel-Wahab N, Shah M, López -Olivo MA, Suarez-Almazor M. A Systematic review of the management of patients with preexisting rheumatologic diseases receiving checkpoint inhibitors for cancer. Arthritis Rheumatol 69 (Suppl 10), 2017.
23. des Bordes JKA, Foreman J, Peterson SK, López -Olivo MA, Westrich-Robertson T, Hofstetter C, Lyddiatt A, Leong AL, Suarez-Almazor ME. Experiences and perceptions of patients with rheumatoid arthritis participating in an online support group: the use of social media. Arthritis Rheumatol 69 (Suppl 10), 2017.
24. López -Olivo MA, Matusevich A, Suarez-Almazor M. Cycling versus swapping in patients with rheumatoid arthritis with an inadequate response to at least one tumor necrosis factor alpha inhibitor: a systematic review and meta-analysis of observational studies. Arthritis Rheumatol 69 (Suppl 10), 2017.
25. Zamora N, López -Olivo MA, Tayar J, Christensen R, Suarez-Almazor M. Comparative effectiveness of tofacitinib versus baricitinib in rheumatoid arthritis using a systematic review and network meta-analysis of randomized trials. Arthritis Rheumatol 69 (Suppl 10), 2017.
26. Chhatwal J, He T, Hur C, López-Olivo MA. Cost-Effectiveness of direct-acting antivirals for HCV treatment: a systematic review of 227 analyses. International Liver Congress™ 2016 - 51st annual meeting of the European Association for the Study of the Liver (EASL), 2016.
27. Pundole X, López -Olivo MA, Cheema H, Sanchez Petitto G, Suarez-Almazor ME, Lu H. Prevention and treatment of bone loss following hematopoietic stem cell transplantation: a systematic review and meta-analysis. Cancer Survivorship Retreat, 2016.
28. des Bordes J, Pratt G, Suarez-Almazor ME, López -Olivo MA. Knowledge, beliefs and concerns about low bone density - a qualitative synthesis. Cancer Survivorship Retreat, 2016.
29. des Bordes J, Pratt G, Suarez-Almazor ME, López -Olivo MA. Pilot testing an educational website on bone health in cancer survivors. Cancer Survivorship Retreat, 2016.
30. López -Olivo MA, des Bordes J, Volk R, Lu H, Edwards B, Suarez-Almazor ME. Development and beta testing of educational websites on bone health in cancer survivors. Cancer Survivorship Research Symposium, 2016.
31. Zamora NV, Tayar J, López -Olivo MA, Christensen R, Suarez-Almazor ME. Baricitinib for rheumatoid arthritis: a systematic review and meta-analysis. Ann Rheum Dis 75 (Suppl 2)(##), 2016.
32. des Bordes J, Pratt G, Suarez-Almazor ME, López -Olivo MA. Knowledge, beliefs and concerns about low bone density - a qualitative synthesis. Division of Internal Medicine Research Retreat, 2016.
33. des Bordes J, Pratt G, Suarez-Almazor ME, López -Olivo MA. Pilot testing an educational website on bone health in cancer survivors. Division of Internal Medicine Research Retreat, 2016.
34. López -Olivo MA, des Bordes J, Volk R, Lu H, Edwards B, Suarez-Almazor ME. Development and beta testing of educational websites on bone health in cancer survivors. Division of Internal Medicine Research Retreat, 2016.
35. Zamora NV, López -Olivo MA, Christensen R, Goel N, Kristensen LE, Strand V, Curtis J, Shea B, Suarez-Almazor ME. Environmental scan of rheumatoid arthritis patient registries around the world: an OMERACT initiative. OMERACT, 2016.
36. López -Olivo MA, Matusevich A, Suarez-Almazor M. Therapy in patients with rheumatoid arthritis (RA) with inadequate response to tumor necrosis factor alpha inhibitors (TNFi): a systematic review and meta-analysis of randomized controlled trials (RCTs) [abstract]. Arthritis Rheumatol 68 (Suppl 10), 2016.
37. Abdel-Wahab N, López -Olivo MA, Suarez-Almazor M. Antiphospholipid antibodies and related clinical events following infection in children: a systematic review of case reports. Arthritis Rheumatol 68 (Suppl 10), 2016.
38. Barbo A, Suarez-Almazor M, López -Olivo MA. Impact of decision-making role preferences in the efficacy of a multimedia patient education tool for patients with common rheumatologic conditions. Arthritis Rheumatol 68 (Suppl 10), 2016.
39. Zamora NV, López -Olivo MA, Christensen R, Goel N, Kristensen LE, Strand V, Curtis JR, Shea B, Suarez-Almazor M. Environmental scan of rheumatoid arthritis patient registries around the world: an OMERACT initiative. Arthritis Rheumatol 68 (Suppl 10), 2016.
40. Zamora NV, Tayar J, López -Olivo MA, Christensen R, Suarez-Almazor M. Baricitinib for rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Rheumatol 68 (Suppl 10), 2016.
41. Garcia SR, López -Olivo MA, Suarez-Almazor M. Treatments for early rheumatoid arthritis (RA): a systematic review of randomized controlled trials. Arthritis Rheumatol 68 (Suppl 10), 2016.
42. Yap A, Dubowitz J, López -Olivo MA, Hernandez M, Pratt G, Hiller J, Gottumukkala V, Sloan E, Riedel G, Schier R. Effect of beta blockers on cancer recurrence, disease-free survival and overall survival: a meta-analysis. 4th Global Conference on Perioperative Care of the Cancer Patient. Royal Marsden NHS Foundation Trust, 2016.
43. Anand V, Anand S, Garg SK, López-Olivo MA, Singh JA. Ofatumumab for rheumatoid arthritis: a cochrane systematic review and meta-analysis. ACP - Boston, 2015.
44. des Bordes J, Hassan N, Suarez-Almazor ME, Lopez-Olivo MA. Assessing information needs on bone health among cancer survivors. Cancer Survivorship Retreat, 2015.
45. López-Olivo MA, Abdel-Wahab N, Dodeja A, Pratt G, Suarez-Almazor ME. Quality appraisal of educational websites on osteoporosis and bone health. Cancer Survivorship Retreat, 2015.
46. Abdel-Wahab N, López-Olivo MA, Talathi S, Suarez-Almazor ME. Risk of developing antiphospholipid syndrome following infection: a systematic review and meta-analysis of observational studies. Division of Internal Medicine Research Retreat, 2015.
47. López-Olivo MA, Barbo A, Rizvi T, Volk R, Lin H, Suarez-Almazor ME. Six-Month effects of a multimedia patient education tool in patients with rheumatoid arthritis. A randomized controlled trial. Arthritis Rheumatol 67 (Suppl 10), 2015.
48. López-Olivo MA, Barbo A, Rizvi T, Volk R, Lin H, Suarez-Almazor ME. Improving outcomes with a multimedia patient education tool in patients with osteoporosis after 6 months. A randomized controlled trial. Arthritis Rheumatol 67 (Suppl 10), 2015.
49. López-Olivo MA, Barbo A, Rizvi T, Volk R, Lin H, Suarez-Almazor ME. A randomized controlled trial to evaluate a multimedia patient education tool in patients with knee osteoarthritis. Six-month results. Arthritis Rheumatol 67 (Suppl 10), 2015.
50. Kakpovbia V, López-Olivo MA, Des Bordes J, Christensen R, Suarez-Almazor ME. The treatment of undifferentiated arthritis: a systematic review and meta-analysis of randomized clinical trials. Arthritis Rheumatol 67 (Suppl 10), 2015.
51. López-Olivo MA, Ojeda-Prias A, Heung E, Leong AL, Willcockson I, Suarez-Almazor ME. Quality assessment of websites providing educational content about rheumatoid arthritis. Arthritis Rheumatol 67 (Suppl 10), 2015.
52. Pundole X, López-Olivo MA, Cheema H, Sanchez Petitto G, Suarez-Almazor ME, Lu H. Prevention and treatment of bone loss following hematopoietic stem cell transplantation: a systematic review and meta-analysis. Arthritis Rheumatol 67 (Suppl 10), 2015.
53. Valerio-Morales IA, López-Olivo MA, Pan X, Suarez-Almazor ME. A phosphodiesterase 4 inhibitor for psoriatic arthritis: systematic review and meta-analysis. Arthritis Rheumatol 67 (Suppl 10), 2015.
54. Basra G, Cardenas-Turanzas M, Andrabi T, French KE, Bellard B, Murphy WA Jr., López-Olivo MA, Suarez-Almazor ME. Fiber optic intubation in patients with rheumatoid arthritis who had a surgical procedure. Arthritis Rheumatol 67 (Suppl 10), 2015.
55. Cardenas-Turanzas M, Gonzalez E, Shethia M, López-Olivo MA, Nayak P, Suarez-Almazor ME. Assessing information needs for chronic disease management in rheumatoid arthritis. Arthritis Rheumatol 67 (Suppl 10), 2015.
56. Anand V, Anand S, Garg S, López-Olivo MA, Singh JA. Ofatumumab for rheumatoid arthritis: a Cochrane systematic review and meta-analysis. Arthritis Rheumatol 67 (Suppl 10), 2015.
57. Bruera S, López-Olivo MA, Barbo A, Suarez-Almazor ME. Use of Medication Reminders in Patients With Rheumatoid Arthritis. Value Health 17(7):A384, 2014. e-Pub 2014. PMID: 27200863.
58. Abdelwahab Hassan N, López-Olivo MA, Siddhanamatha HR, Suarez-Almazor ME. The relationship between infection and anti-phospholipid syndrome: A systemic review of case reports. Ann Rheum Dis 73 (Suppl 3)(608), 2014.
59. Abdelwahab Hassan N, López-Olivo MA, Siddhanamatha HR, Suarez-Almazor ME. The relationship between infection and anti-phospholipid syndrome: A systemic review of case reports. Division of Internal Medicine Research Retreat, 2014.
60. McGahan L, López-Olivo MA, Amezaga M, Polono N.E., Suarez-Almazor ME. Rituximab in rheumatoid arthritis. Canadian Cochrane Symposium, 2014.
61. Abdel-Wahab N, López-Olivo MA, Talathi S, Suarez-Almazor ME. Risk of developing antiphospholipid syndrome following infection: a systematic review and meta-analysis of observational studies. Arthritis Rheum (Suppl) 66(11)(S432), 2014.
62. Pan X, López-Olivo MA, Nayak P, Suarez-Almazor ME. Quality assessment of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis: a systematic review. Arthritis and Rheumatology 66 (11 Suppl)(S1055), 2014.
63. Peddi P, López-Olivo MA, Pratt G, Suarez-Almazor M. Denosumab in patients with cancer and skeletal metastases. Division of Internal Medicine Research Retreat, 2012.
64. López-Olivo MA, Pratt G, Salahudeen A. Rasburicase for the treatment and prevention of tumor lysis sundrome in adults. Division of Internal Medicine Research Retreat, 2012.
65. Waimann CA, Fernandez-Mazarambroz RJ, Cantor S, López-Olivo MA, Zhang H, Landon GC, Siff SJ, Suarez-Almazor ME. Impact of psychosocial determinants on total knee replacement (TKR) costs: results from the patient expectations about knee surgery (PEAKS) cohort. Arthritis Rheum 63(Suppl 10):S345, 2011.
66. Shah N, Pratt G, Suarez-Almazor M, López-Olivo MA. Efficacy of bisphosphonates for bone metastases in patients with lung cancer: a systematic review and meta-analysis. Division of Internal Medicine Research Retreat, 2011.
67. Waimann CA, Fernandez-Mazarambroz RJ, Cantor S, López-Olivo MA, Zhang H, Landon GC, Siff SJ, Suarez-Almazor ME. Impact of slow recovery and poor functional outcomes on direct and indirect costs after total knee replacement in osteoarthritis patients. Arthritis Rheum 63(Suppl 10):S347, 2011.
68. López-Olivo MA, Tayar JH, Suarez-Almazor ME. Febuxostat for the treatment of chronic recurrent gout: a meta-analysis. Ann Rheum Dis 69(Suppl 3):608, 2010.
69. López-Olivo MA, Suarez-Almazor ME, Shaw Y. A systematic review to appraise the quality of cost-effectiveness studies of biologic agents for the treatment of rheumatoid arthritis. Ann Rheum Dis 69(Suppl3):642, 2010.
70. López-Olivo MA, Martinez-Lopez JA, Tayar JH, Polo Cueto J, Pollono EN, Gonzales-Crespo MR, Fulton S, Suarez-Almazor ME. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: meta-analysis of controlled trials. Arthritis Rheum 62(Suppl):S171-2, 2010.
71. López-Olivo MA, Kallen MA, Pak CH, Siff SJ, Landon GC, Edelstein D, Robinson KC, Suarez-Almazor ME. Using the patient generated index (PGI) to measure personalized quality of life (QoL) in patients undergoing total knee arthroplasty (TKA). Arthritis Rheum 62(Suppl):S74, 2010.
72. López-Olivo MA, Shaw Y, Suarez-Almazor ME. A systematic review to appraise the quality of cost-effectiveness studies of biologic agents for the treatment of rheumatoid arthritis. Arthritis Rheum 62(Suppl):S315, 2010.
73. Marengo MF, Waimann CA, López-Olivo MA, Looney C, Suarez-Almazor ME. Controversies in the use of acupuncture for osteoarthritis (OA): a systematic review of the quality and treatment features of randomized clinical trials (RCT). Arthritis Rheum 62(Suppl):S389-90, 2010.
74. López-Olivo MA, Martinez-Lopez JA, Polo Cueto J, Pollono EN, Gonzalez-Crespo MR, Fulton S, Suarez-Almazor ME. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: meta-analysis of controlled trials. Division of Internal Medicine Research Retreat, 2010.
75. López-Olivo MA, Kallen M, Pak C, Siff SJ, Landon GC, Edelstein D, Robinson KC, Zhang H, Suarez-Almazor ME. Psychosocial and educational barriers to surgical success after knee arthroplasty. Arthritis Rheum 60(Suppl 10), 2009.
76. López-Olivo MA, Kallen MA, Ortiz Z, Roundtree AK, Skidmore B, Suarez-Almazor ME. Scientific validity of clinical practice guidelines for the use of infliximab and etanercept in rheumatoid arthritis. Arthritis Rheum 56(Suppl 9), 2007.
77. Suarez-Almazor ME, Roundtree AK, Kallen MA, López-Olivo MA, Ortiz Z, Skidmore B. Systematic review of reviews on the use of biologics for rheumatoid arthritis. Arthritis Rheum 56(Suppl 9), 2007.
78. López-Olivo MA, Kallen MA, Richardson MN, Garcia-Gonzalez A, Cox VL, Lidsky L, Ng B, Marcus D, Reveille JD. Effect of depression and social support on the self-reported adherence in patients with rheumatic diseases. Arthritis Rheum 56(Suppl 9:):118, 2007.
79. López-Olivo MA, Kallen MA, Richardson MN, Garcia-Gonzalez A, Cox VL, Lidsky M, Ng B, Marcus D, Reveille JD. Treatment adherence and use of reminders in patients with rheumatic disease. Arthritis Rheum 56(Suppl 9:110), 2007.
80. López-Olivo MA, Kallen MA, Pak CH, Siff SJ, Landon GC, Eldestein D, Suarez-Almazor ME. Role of social support and depression on pain and function in patients undergoing total knee arthroplasty (TKA). Arthritis Rheum 56(Suppl 9), 2007.
81. Suarez-Almazor ME, López-Olivo MA, Pak CH, Skidmore B. Long-term effectiveness during infliximab or etanercept therapy: A systematic review of observational studies. Arthritis Rheum 56(Suppl 9), 2007.
82. López-Olivo MA, Andrabi TR, Suarez-Almazor ME. Cervical spine instability in patient with rheumatoid arthritis (RA) undergoing general surgery. Arthritis Rheum 56(Suppl 9), 2007.
83. Gossec L, Jordan JM, Mazzuca SM, Lam MA, Suarez-Almazor ME, Renner JB, López-Olivo MA, Hawker G, Dougados M, Maillefert JF, Groupe de travail OARSI-OMERACT. La mesure de l’interligne articulaire est un meilleur indice structural dans la gonarthrose que les scores semi-quantitatifs : étude comparative de 3 méthodes d’évaluation de l’arthrose dans 1759 radiographies. French Rheumatology Society, 2007.
84. López-Olivo MA, Kallen M, Ortíz Z, Kendall Roundtree A, Skidmore B, Suárez-Almazor M. Validez científica de las guías de práctica clínica sobre el uso del infliximab, etanercept y adalimumab en artritis reumatoide. VI Jornada Nacional de la Sociedad Argentina para la Calidad en Atención de la Salud, 2007.
85. Suarez-Almazor ME, López-Olivo MA, Pak C, Ortiz Z, Cox VL, Skidmore B. Long-term effectiveness during infliximab or etanercept therapy: a systematic review of observational studies. Ann Rheum Dis 66(Suppl II):601, 2007.
86. Alcaraz-Lopez MF, Aguilar-Chavez EA, Sandoval-Ramirez L, Loaiza-Cardenas CA, López-Olivo MA, Salazar-Paramo M, Davalos-Rodriguez IP, Martinez-Corral ME, Gamez-Nava JI , Gonzalez-Lopez L. Clinical, epidemiological factors and TAQI genotype of the vitamin D receptor in osteoporosis associated with rheumatoid arthritis. Ann Rheum Dis 66(Suppl II):591, 2007.
87. López-Olivo MA, Roundtree AK, Ortiz Z, Skidmore B, Suarez-Almazor ME. Switching between anti-TNF agents treatments for rheumatoid arthritis: a systematic review. Ann Rheum Dis 66(Suppl II):189, 2007.
88. Gossec L, Jordan JM, Lam M, Suarez-Almazor ME, Mazzuca S, Renner JB, López-Olivo MA, Hawker G, Dougados M, Maillefert J. Measurement of joint space width appears to be the most valid indicator of structural damage in knee osteoarthritis: a comparative study of 3 radiographic scores in 1759 x-rays. Ann Rheum Dis 66(Suppl II):58, 2007.
89. López-Olivo MA, Suarez-Almazor ME, Moffett ML. Economic evaluation of biologic therapies in ankylosing spondylitis: a systematic review. Ann Rheum Dis 66(Suppl II):274, 2007.
90. Gonzalez-Lopez L, Sanchez-Hernandez JD, Aguilar-Chavez EA, Villa-Manzano AI, Cota-Sánchez AR, López-Olivo MA, Alonso-Gamiño L, Espinoza-Magaña GLC, Cardona-Muñoz EG, Rojo-Contreras EW, Gamez-Nava JI. Hyperhomocysteinemia in ankylosing spondylitis. Ann Rheum Dis 66(Suppl II):613, 2007.
91. López-Olivo MA, Roundtree AK, Skidmore B, Suarez-Almazor ME. A systematic review on the occurrence of cancer in patients with rheumatoid arthritis while on treatment of anti-TNF-α agents. Division of Internal Medicine Research Retreat(Abstract C3), 2007.
92. López-Olivo MA, Moffett MM, Kallen MA, Ortiz Z, Skidmore B, Suarez-Almazor ME. Economic evaluation of infliximab and etanercept: a systematic review. Ann Rheum Dis 65(Suppl II):329, 2007.
93. López-Olivo MA, Ortiz Z, Pak CH, Cox V, Kimmel B, Kendall-Roundtree A, Skidmore B, Suarez-Almazor ME. A meta-analysis on the timing of therapeutic introduction of infliximab (IFX) and etanercept (ETN). Ann Rheum Dis 65(Suppl II):329, 2006.
94. Gamez-Nava JI, Corona-Sanchez E, Aguilar-Chavez E, Muñoz-Valle J, Galvan-Melendez S, Loaiza-Cardenas C, López-Olivo MA, Ortega-Flores R, Salazar-Paramo M, Rojo-Contreras E, Vazquez-Del Mercado M, Gonzalez-Lopez L. Serum-soluble E-selectin levels in active rheumatoid arthritis. Ann Rheum Dis 65(Suppl II):629, 2006.
95. Aguilar-Chavez EA, Gonzalez-López L, López-Olivo MA, Alcaraz-Lopez MF, Corona-Sanchez EG, Galvan-Melendez S, Loaiza-Cardenas C, Varón-Villalpando E, Rojo-Contreras EW, Gamez-Nava JI. Association between serum leptin levels and disease activity in rheumatoid arthritis. Ann Rheum Dis 65(Suppl II):628, 2006.
96. Suarez-Almazor, ME, López-Olivo MA, Kendall-Roundtree A, Ortiz Z, Skidmore B. Dose escalation in anti-TNF therapy for rheumatoid arthritis (RA) a systematic review. Ann Rheum Dis 65(Suppl II):603, 2006.
97. López-Olivo MA, Ortiz Z, Pak CH, Cox V, Kimmel B, Kendall-Roundtree A, Skidmore B, Suarez-Almazor ME. A meta-analysis on the timing of therapeutic introduction of infliximab (IFX) and etanercept (ETN). Arthritis Rheum 54(Suppl):243, 2006.
98. López-Olivo MA, Moffett ML, Kallen MA, Ortiz Z, Skidmore B, Suarez-Almazor B. Economic evaluation of infliximab and etanercept: A systematic review. Arthritis Rheum 54((9:Suppl)):336, 2006.
99. López-Olivo MA, Moffett ML, Cox VL, Richardson MN, Garcia-Gonzalez A, Suarez-Almazor ME. Association of SF-6D health utilities with activity and side effects in patients with systemic lupus erythematosus. Arthritis Rheum 54((9:Suppl)):335-6, 2006.
100. López-Olivo MA, Garcia-Gonzalez A, Kallen MA, Richardson MN, Cox VL, Janssen NM, Marcus DM, Reveille JD, Warner NB, Suarez-Almazor ME. Social support and quality of life in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Arthritis Rheum 54((9:Suppl)):335-6, 2006.
101. Corona-Sanchez EG, Gonzalez-Lopez L, Ayala-Lopez K, Aguilar-Chavez EA, Munoz-Valle F, Galvan-Melendez S, Loaiza-Cardenas C, López-Olivo MA, Ortega-Flores R, Salazar-Paramo M, Vazquez-Del Mercado M, Gamez-Nava JI. Levels of serum soluble E-selectin in active rheumatoid arthritis. Arthritis Rheum 54((9:Suppl)):379, 2006.
102. Sanchez-Hernandez JD, López-Olivo MA, Aguilar-Chavez E. Differences in the perception of health-related quality of life between men and women with ankylosing spondylitis. J Rheumatol 33((2):Suppl):408-408, 2006.
103. Alcaraz-Lopez MF, Gonzalez-Lopez L, Aguilar-Chavez E, López-Olivo MA, Loaiza-Cardenas C, Gamez-Nava JI. Perfomance of Albrand index for identifying low bone density in rheumatoid arthritis. J Rheumatol 33((2):Suppl):408-409, 2006.
104. Aguilar-Chavez EA, Gonzalez-López L, López-Olivo MA, Galvan-Melendez S, Loaiza-Cardenas C, Alcaraz-Lopez MF, Gamez-Nava JI. Association between serum leptin levels and disease activity in rheumatoid arthritis. J Rheumatol 33((2:Suppl)):409, 2006.
105. López-Olivo MA, Garcia-Gonzalez A, Kallen MA, Richardson MN, Cox VL, Janssen NM, Marcus DM, Reveille JD, Warner NB, Suarez-Almazor ME. Social support and quality of life in patients with rheumatoid arthritis. J Rheumatol 33((2:Suppl)):422-423, 2006.
106. Sandoval Ramirez L, Casillas Avila MP, Alcaraz-López MF, Aguilar-Chavez EA, López-Olivo MA, Davalos Rodriguez IP, Salazar-Paramo M, Gonzalez-López L, Gamez-Nava JI. Frecuencia de polimorfismos del gen receptor de vitamina D en pacientes con artritis reumatoide y controles sanos. Reumatol Clin 2(1):(77), 2006.
107. Casillas-Avila MP, Gonzalez-López L, López-Olivo MA, Alcaraz F, Agilar Chavez EAG, Gamez-Nava JI, Salazar Paramo M, Davalos IP, Figuera LE, Mena-Ramirez JP, Sandoval Ramirez L. Asociación entre la osteoporosis en artritis reumatoide con polimorfismo del gen del receptor de vitamina D. Respyn - UANL MX, 2006.
108. Rojo Contreras EW, Gonzalez-López L, Ayala Lopez KP, López-Olivo MA, Morales Romero J, Vazquez Salcedo J, Castillo Gonzalez J, Gamez-Nava JI. Disfuncion sexual en lupus eritematoso sistemico. Reumatol Clin 2(1):((40)), 2006.
109. Morales-Romero J, Gonzalez-López L, Garcia-Gonzalez A, López-Olivo MA, Villa-Manzano AI, Rosales-Cervantes MC, et al. Motivos y frecuencia de incapacidad laboral en pacientes con artritis reumatoide (AR) y espondilitis anquilosante (EA). Rev Mex Reumatol 19(1):((21)), 2004.
110. Gamez-Nava JI, Villa-Manzano AI, Garcia-Gonzalez A, López-Olivo MA, Garcia-Gonzalez G, Valera-Gonzalez I, Salazar-Paramo M, Morales-Romero J, Gonzalez-López L. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythermatosus. Arthritis Rheum 48((9:Suppl)):1487, 2003.
111. López-Olivo MA, Gonzalez-López L, Gámez-Nava JI, Salazar-Páramo M, García-González A, Villa-Manzano AI, Cota Sánchez AR.. Serum homocysteine levels in patients with rheumatoid arthritis. Rev. Mex. Reumatol 18(52), 2003.
112. Morales-Romero J, López-Olivo MA, Villa-Manzano AI, García-González A, Hernandez-Romo JA, Gámez-Nava JI, Gonzalez-López L.. Pain and perception of difficulty for the sexual relation: factors of risk for depression in rheumatoid arthritis. Rev. Mex. Reumatol 18(34), 2003.
113. Garcia-Gonzalez A, Villa-Manzano AI, López-Olivo MA, Salazar-Páramo M, González-Valera I, Gámez-Nava JI, García-González G, Ornelas-Torres JC, Gonzalez-López L, Cardona-Muñoz EG.. Comparison in serum levels of procollagen aminoterminal propeptides I and III in patients with systemic lupus erythematosus. Rev. Mex. Reumatol 18(29), 2003.
114. Morales Romero J, López Sandoval I, Perez Serna JC, López-Olivo MA, Villa Manzano AI, Aguilar Chavez EAG, Gonzalez Lopez L, Gamez Nava JI. Physician's behaviour regarding the use of alternative medicine in patients with rheumatoid arthritis. X Annual Meeting of the National Research Congress of Public Health, 2003.
115. Garcia Gonzalez A, Gonzalez López L, Ornelas Aguirre JM, Morales Romero J, Villa Manzano Al, López-Olivo MA, Games Nava JI. Quality of life predictors in patients with rheumatoid arthritis. Rev Mex Reumatol 17(69), 2002.
116. Garcia-Gonzalez A, Gonzalez-López L, Ornelas-Aguirre JM, Morales-Romero J, Villa-Manzano AI, López-Olivo MA, Gamez-Nava JI. Predictors of quality of life in patients with ankylosing spondylitis. Rev Mex Reumatol 17(69), 2002.

Book Chapters

1. López-Olivo MA. Patient education and shared-decision making. In: Cancer Immunotherapy Induced Rheumatic Diseases and Syndromes. A Handbook for Diagnosis and Management. Springer, 2020.
2. Suarez-Almazor ME, López-Olivo MA, Ortiz Z.. Epidemiología clínica de las enfermedades reumáticas. In: Reumatologia: Argentina, 2010.
3. López-Olivo MA, Suarez-Almazor ME. Evaluaciones económicas de los antagonistas del factor de necrosis tumoral alfa en la espondilitis anquilosante. In: Espondilitis anquilosante y otras espondiloartritis. Permanyer Publications: Spain, 2009.
4. López-Olivo MA, Suarez-Almazor ME. Esclerosis sistemica y epidemiologia. In: Esclerosis Sistemica: Mexico, 2009.
5. López-Olivo MA, Suarez-Almazor ME. Costo-efectividad de la terapia biologica en las enfemedades reumaticas. In: Teraia biologica en las enfermedades reumaticas. Doyma Masson Publications: Spain, 2006.